Mission

At Eyam, our mission is to design, develop and bring to market next generation platform technologies for safer and more effective vaccines and therapeutics.

Eyam’s Gemini Platform combines the power of RNA and the stability of DNA for a safe, highly effective, and easy-to-manufacture solution.

Our Vision is to usher in the golden age of safer, more effective, and lower dose vaccines and therapeutics.

Our Vision is to usher in the golden age of safer, more effective, and lower dose vaccines and therapeutics.

Our History

Eyam is a private, Canadian company focused on the research, development, and commercialization of platform technologies that are safe, efficacious and low dose.

Eyam, was named to honour the village in Derbyshire that, in 1665-1666, confronted the plague. Villigers of Eyam choose to stay and brave near curtain death rather than fleeing and risking the transmission of plague to neighboring villages. In the end, 75% of Eyam’s residents did indeed die, but their surrounding neighbors were spared due to Eyam’s heroic and selfless quarantine.

Our History

Eyam is a private, Canadian company focused on the research, development, and commercialization of platform technologies that are safe, efficacious and low dose.

Eyam, was named to honour the village in Derbyshire that, in 1665-1666, confronted the plague. Villigers of Eyam choose to stay and brave near curtain death rather than fleeing and risking the transmission of plague to neighboring villages. In the end, 75% of Eyam’s residents did indeed die, but their surrounding neighbors were spared due to Eyam’s heroic and selfless quarantine.

EYAM’S RESEARCH

Teaching the Body to Fight

Eyam’s scientists have developed a novel vaccines and therapeutics platform to protect against and fight diseases.